Dr. Ellen Schur is quoted in NPR
Dr. Ellen Schur, professor (General Internal Medicine) is quoted in “Some doctors have stopped recommending weight loss. Here’s why” from NPR.
Read MoreDr. Ellen Schur, professor (General Internal Medicine) is quoted in “Some doctors have stopped recommending weight loss. Here’s why” from NPR.
Read MoreDr. Gregory Morton, research professor (Metabolism, Endocrinology and Nutrition) is senior author of “High-Fat Diet Feeding Disrupts the Coupling of Thermoregulation to Energy Homeostasis” in Molecular Metabolism. DOM co-authors are
Read MoreDr. Michael Schwartz, professor (Metabolism, Endocrinology and Nutrition) is quoted in “Wegovy, Ozempic Help Folks Lose Weight, But How?” in HealthDay.
Read MoreAlan Chait Award for Excellence in Mentorship Congratulations to Dr. Mauricio Dorfman, research assistant professor, and Dr. Farah Khan, clinical associate professor, this year’s recipients of the Alan Chait Award
Read MoreDr. Irl Hirsch, professor (Metabolism, Endocrinology and Nutrition) is co-author of “Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine” in Nature Medicine.
Read MoreMore study needed into the ‘why’ of new weight-loss drugs Hitting the market over the past six years, the drugs Ozempic, Wegovy and Mounjaro are viewed as a therapeutic breakthrough
Read MoreAn image by Dr. Alan Chait, professor emeritus (Metabolism, Endocrinology and Nutrition) is featured on the cover of the August issue of Diabetes Care.
Read MoreDr. Joshua Thaler is senior author on a publication in Cell Metabolism entitled “Obesity-associated microglial inflammatory activation paradoxically improves glucose tolerance” which is featured as a Research Highlight in Nature
Read MoreDr. Irl Hirsch, professor (Metabolism, Endocrinology and Nutrition) is quoted in “Drugmakers Promised Cheaper Insulin but Diabetics Can’t Find It” from Bloomberg Law.
Read MoreDr. Irl Hirsch, professor (Metabolism, Endocrinology and Nutrition) is quoted in “Affording the Cost of New Obesity Drugs? We Can’t Afford Not to” in Medscape.
Read More